September 7, 2025 World Duchenne Awareness Day: Celebrating 10 Years of D-RSC’s Commitment to Serve the Duchenne Community Today is the World Duchenne Awareness Day (WDAD), an annual event that raises global awareness and understanding of Duchenne...
September 8, 2025 C-Path Welcomes Rare Disease Advocacy Leader Ronald J. Bartek to Board of Directors C-Path today announced the election of Ronald J. Bartek to its Board of Directors...
September 4, 2025 C-Path’s Translational Therapeutics Accelerator Marks Record Year with Seven BRIDGe Awards Advancing Potential Therapies Across Cancer, Infectious Disease, Neurology and Immunology Program launched in 2022 has grown into a global pipeline partner for academic teams, awarding approximately $2.48 million...
September 4, 2025 From Data to Hope: C-Path’s Polycystic Kidney Disease Outcomes Consortium and the Power of Data Sharing Every year on September 4, families, patients, advocates, and researchers come together to recognize Polycystic Kidney Disease...
September 8, 2025 Shaping the Future of AATD: Patient Perspectives to Drive the Next Decade of Innovation in Alpha-1 Antitrypsin Deficiency On September 8, C-Path and the Alpha-1 Foundation are co-hosting a virtual workshop, Shaping the Future of AATD: Patient...
August 21, 2025 HDYO Joins C-Path’s Huntington’s Disease Consortium to Amplify Youth Voices in Drug Development TUCSON, Ariz., August 21, 2025 — Critical Path Institute’s® (C-Path) Huntington’s Disease Regulatory Science Consortium...
August 19, 2025 C-Path’s Translational Therapeutics Accelerator Announces $473,000 Grant for Drug Development Project in Primary Sclerosing Cholangitis TUCSON, Ariz, August 19, 2025 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) has...
August 14, 2025 Honoring Our Partners on National Nonprofit Day: Celebrating 20 Years of Advancing Regulatory Science at C-Path Sunday, August 17, represents National Nonprofit Day, a time to recognize the profound impact that nonprofit organizations have...
August 7, 2025 C-Path Awards Translational Therapeutics Accelerator Grant to Advance First-in-Class Antibiotic for Drug-Resistant Lung Infections TUCSON, Ariz., Aug. 7, 2025 ⎯ Critical Path Institute® (C-Path) announced today that its Translational Therapeutics...
August 7, 2025 Critical Path Institute’s Translational Therapeutics Accelerator Awards $150,000 Grant to Support a Novel Drug Approach in Hereditary Spastic Paraplegia TUCSON, Ariz., August 7, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) has...